Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.

1992 • 734 citations

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1991 • 668 citations

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck.

1992 • 617 citations

Relationships between the structure of taxol analogs and their antimitotic activity

1991 • 538 citations

Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.

1991 • 480 citations

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

1984 • 262 citations

Head and neck cancer: chemotherapy concepts.

1988 • 181 citations

Coping with toxicities of docetaxel (TaxotereTM)

1993 • 145 citations

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

1992 • 138 citations

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion.

1993 • 133 citations

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells

1992 • 129 citations

Effects of taxotere on murine and human tumor cell lines

1992 • 129 citations

Use of paclitaxel (Taxol) in squamous cell carcinoma of the head and neck.

1993 • 61 citations

Antitumor activity of taxotere (RP 56976, NSC 628503), a new taxol analog, in experimental ovarian cancer

1993 • 25 citations

Cited By (0)

Loading...